/
/
HealthTree for AML Radio: Progress Toward an All Oral Treatment for Newly Diagnosed Older Adult...

Event Description

In this HealthTree Radio for AML show, Dr. Gabriel Mannis talks about treatment options for older adults with AML. He reviews his open clinical trial looking at what could be the first all-oral treatment for newly diagnosed older patients. The combination of venetoclax and decitabine with cedazuridine (ASTX727 or Inqovi) would provide older adults with AML and those who cannot tolerate standard intensive chemotherapy a much-needed alternative treatment option.

To listen to the recording or read the transcript of this past radio show,

click here

Schedule & Agenda

03:00PM - 04:00PM
03:00PM
Welcome
Welcome, announcements and introduction
03:05PM
Interview
Dr. Mannis answers questions about his open clinical trial: Pharmacokinetics, Safety, and Efficacy of Decitabine/Cedazuridine (ASTX727) in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
03:50PM
Q&A
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Mannis questions.

Speakers & Moderators

The author Gabriel Mannis, MD
Gabriel Mannis, MD
Palo Alto, CA

Hematologist Oncologist, Assistant Professor Of Hematology

The author Katie Braswell
Katie Braswell
Dallas, Texas

Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.

Have Any Questions?

Thank you for your interest in the event. If you have any question, we would love to help! Just fill out the form below and we will get back to you as quickly as possible.

support

Get In Touch With Us

phone

(800) 930-5159

email

Support@healthtree.org

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811